CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
about
Profile of palbociclib in the treatment of metastatic breast cancerEmerging therapies for breast cancerPDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signalsTopotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma.Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib.Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity
P2860
Q26747737-862A0AA6-CD34-4093-B1D6-B1564CF752F9Q33617949-64DB84CF-52D0-4488-BBF2-0E8B3BFA7286Q37619702-B6CBB7C0-3614-41FB-B5C7-3E532F61574CQ41287854-50F077B6-6150-4E01-8398-8BF7B8E08096Q47107760-644C2E97-8047-4717-99B8-D1A3D9B053D9Q47115276-F8E1724F-00C5-4C11-817E-EBCCF0CA9EEDQ47169141-770CF4D7-B1D3-402B-8C21-F04E68987146Q58746764-36CB884B-5D4D-4B89-A914-9EE283141504
P2860
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
@en
type
label
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
@en
prefLabel
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
@en
P2860
P356
P1476
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
@en
P2093
Kerrie L McDonald
Lisette B W Schröder
P2860
P356
10.3389/FONC.2015.00259
P577
2015-11-30T00:00:00Z